Bob Burrows | Vice President, Investor Relations |
Dan Abdun Nabi | President and Chief Executive Officer |
Bob Kramer | Executive Vice President and Chief Financial Officer |
Laura Saward | SVP, Antibody Therapeutics Business Unit Head |
Jessica Fye | JP Morgan. |
Eric Schmidt | Cowen and Company |
David Maris | Wells Fargo |
Dana Flanders | Goldman Sachs. |
François Brisebois | Laidlaw |
Lisa Springer | Singular Research |
Good day, ladies and gentlemen, and welcome to the Four Quarter 2017 Emergent BioSolutions Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] And as a reminder, this conference is being recorded. I would now like to turn the call over to the company.